Soreide Law Group has been contacted by clients who purchased Onconova Therapeutics, Inc. (ONTX) and experienced significant stock losses through the sale of the stock brokers at Laidlaw and Company. Laidlaw is listed on their website as the “Sole Book Runner” from the April 2017 offering. Securities that are newly issued are often more volatile than the more established companies, and if you, as the investor, were not looking to speculate, this could have been a highly unsuitable recommendation given to you by your broker from Laidlaw and Company.
According to Yahoo Finance, Onconova Therapeutics, Inc. (ONTX), a clinical-stage biopharmaceutical company, focusing on discovering and developing small molecule product candidates to treat cancer. The company has a license agreement with SymBio Pharmaceuticals Limited; a development and license agreement with Baxter Healthcare SA; a license, development, and commercialization agreement with Pint International SA; and a license and collaboration agreement with HanX Biopharmaceuticals, Inc. Onconova Therapeutics, Inc. was founded in 1998 and is headquartered in Newtown, Pennsylvania.
In April of 2017, Onconova Therapeutics, Inc. (ONTX) was trading around 2.7, and today it is trading at approximately 0.37. The 52-week change is -81.89%%.
On Laidlaw and Company’s website, the following information on their company is given:”Our team of bankers’ focus on the healthcare industry and the depth of their experience allows them to provide comprehensive knowledge of both the industry and the markets.”
If you’ve experienced financial losses in Onconova Therapeutics, Inc. (ONTX) due to the recommendations of Laidlaw and Company’s securities brokers, call Soreide Law Group for a no cost consultation with an experienced securities lawyer regarding the possibility of recovering your significant financial losses through a FINRA arbitration at: 888-760-6552.
Soreide Law Group represents our clients nationwide before FINRA. We operate on a contingency fee basis, no fee if no recovery.
Investors potentially experienced sales practice violations by securities broker Russell Glenn Bedore [CRD: 4729849, Deerfield Beach, Florida], according to information disclosed through Financial Industry Regulatory Authority (FINRA) BrokerCheck. Bedore has been registered with LPL Financial LLC since May 14, 2026, and previously worked for J.P. Morgan Securities LLC from July 15, 2013, through May 15, […]
Investors might have sustained losses due to securities broker Matthew James Kloos [CRD: 7292988, Monroeville, Pennsylvania], based on public information on Financial Industry Regulatory Authority (FINRA) BrokerCheck. Matthew Kloos worked for Cetera Investment Services LLC from February 21, 2024, to April 23, 2026, and previously worked for Mutual of Omaha Investor Services Inc. from August […]
Investors potentially experienced sales practice violations by securities broker Melissa Star Williams (also known as Melissa Star Bortfeld, Melissa Starr Williams, Melissa Williams Frasca) [CRD: 4298503, Spokane, Washington], according to disclosures on Financial Industry Regulatory Authority (FINRA) BrokerCheck. Williams worked for Centaurus Financial Inc. from August 28, 2015, through March 14, 2024, before registering with […]
Phone:
Fax: 1-954-760-6553
Email: info@securitieslawyer.com